Urinary tract infections are among the most common bacterial infections nurses encounter across every care setting — from primary care and the ED to med-surg and the ICU. UTIs account for approximately 8–10 million outpatient visits annually in the United States, and catheter-associated UTI (CAUTI) remains one of the most common healthcare-acquired infections. Understanding the distinction between lower and upper tract infection, interpreting urinalysis findings accurately, and recognizing atypical presentations in vulnerable populations are core nursing competencies — and frequent NCLEX topics.
This reference covers the full spectrum of lower urinary tract infection (cystitis): classification, causative organisms, diagnostic workup, nursing assessment, antibiotic management, special populations including CAUTI, prevention, and NCLEX-style practice questions. For upper tract infection (pyelonephritis) and urosepsis, see the pyelonephritis nursing reference.
Quick reference: UTI types
| Type | Location | Classic symptoms | UA hallmark | Treatment duration |
|---|---|---|---|---|
| Uncomplicated cystitis | Bladder / lower tract | Dysuria, frequency, urgency, suprapubic pain | Leukocyte esterase +, nitrites +, pyuria | 3–7 days |
| Complicated cystitis | Bladder / lower tract | Same + risk factors (male, catheter, diabetes, pregnancy) | Pyuria, bacteriuria; culture required | 7–14 days |
| Pyelonephritis | Kidney / upper tract | Fever, chills, CVA tenderness, flank pain | WBC casts (upper-tract specific), pyuria | 7–14 days |
| CAUTI | Any; catheter-related | Systemic symptoms (fever, rigors, flank pain, new altered mental status) | Pyuria alone is insufficient — systemic signs required | 7–14 days |
Classification: lower vs upper tract
The urinary tract is divided into lower (urethra and bladder) and upper (ureters, renal pelvis, kidney parenchyma). This distinction drives clinical management.
Lower urinary tract infection (cystitis):
- Bacterial colonization limited to the bladder urothelium
- Inflammation is local — no systemic inflammatory response
- Fever is absent or low-grade (fever suggests upper tract involvement)
- Responds to short-course oral antibiotics
Upper urinary tract infection (pyelonephritis):
- Ascending bacteria have reached the renal pelvis and parenchyma
- Triggers a systemic inflammatory response — fever ≥38°C, rigors, systemic symptoms
- Costovertebral angle (CVA) tenderness is present
- May progress to bacteremia and urosepsis
- Requires longer antibiotic courses; may require IV therapy
Uncomplicated vs complicated UTI:
| Feature | Uncomplicated | Complicated |
|---|---|---|
| Patient | Healthy, premenopausal, non-pregnant woman | Male, pregnant, catheterized, immunosuppressed, diabetes, structural abnormality |
| Location | Lower tract (cystitis) | Any location |
| Typical organism | E. coli | E. coli, plus broader range including Pseudomonas, Enterococcus, Candida |
| Treatment duration | 3–5 days | 7–14 days |
| Culture required? | No (clinical diagnosis) | Yes — always culture |
| Risk of treatment failure | Low | Higher |
The key clinical rule: any UTI in a man is considered complicated. UTIs in men are rare (female anatomy is the major risk factor) and when they occur, underlying structural pathology or prostatitis involvement is common enough that all male UTIs require urine culture and longer treatment.
Causative organisms and risk factors
Organisms
| Organism | Frequency | Clinical notes |
|---|---|---|
| Escherichia coli | ~80–85% of community-acquired cystitis | Dominant pathogen; virulence factors include fimbriae for urothelial adhesion |
| Staphylococcus saprophyticus | 5–15% in young sexually active women | Second most common in this demographic; often nitrite-negative on dipstick |
| Klebsiella pneumoniae | ~8% | More common in diabetics and hospital-acquired infections |
| Proteus mirabilis | ~5% | Associated with struvite stones; urea-splitting raises urine pH |
| Enterococcus faecalis | ~5% | More common in men and complicated UTIs; ampicillin-susceptible |
| Pseudomonas aeruginosa | Low in community; higher in CAUTI | Hospital-acquired; intrinsically resistant to many antibiotics |
| Candida spp. | Up to 24% of CAUTI | Fungal infection; treat only if symptomatic or immunosuppressed |
Clinical pearl: Staphylococcus saprophyticus is nitrite-negative on dipstick (it does not reduce nitrates). A negative nitrite result does not rule out UTI — this is especially important in young women.
Risk factors
| Risk factor | Mechanism |
|---|---|
| Female anatomy | Short urethra (~4 cm), proximity to rectum; easier bacterial access to bladder |
| Sexual activity | Mechanical urethral inoculation (“honeymoon cystitis”) |
| Diaphragm / spermicide use | Alters vaginal flora; spermicides kill protective lactobacilli |
| Menopause | Loss of estrogen → reduced lactobacilli → increased vaginal pH → colonization risk |
| Pregnancy | Ureteral dilation (progesterone), uterine compression, altered immune tolerance |
| Diabetes mellitus | Glucose-rich urine supports bacterial growth; impaired neutrophil function |
| Urinary catheterization | Bypasses urethral defenses; biofilm forms within 24–48 hours |
| Urinary obstruction | Stasis promotes bacterial overgrowth |
| Prior UTIs | Altered mucosal defenses; colonization with uropathogenic strains |
| Immunosuppression | Reduced ability to clear ascending bacteria |
Signs and symptoms
Classic lower tract presentation (cystitis)
- Dysuria — burning or pain with urination; the most sensitive symptom
- Urinary frequency — need to void more often than usual with small volumes
- Urinary urgency — sudden, compelling need to void
- Suprapubic pain or pressure — tenderness over the bladder (midline, lower abdomen)
- Hematuria — visible blood in urine in approximately 20–30% of cases; may present as pink-tinged or frank red urine
- Cloudy or foul-smelling urine — from pyuria and bacteriuria
What is absent in uncomplicated cystitis: fever ≥38°C, rigors, flank pain, CVA tenderness, nausea/vomiting. The presence of any of these features shifts the diagnosis toward pyelonephritis and must prompt reassessment.
Atypical presentations
Elderly patients: Classic symptoms are frequently absent. Older adults — particularly those with dementia or cognitive impairment — may present with:
- New or worsening confusion or agitation
- Increased falls
- Generalized weakness or lethargy
- New incontinence
- Anorexia or refusal to eat
This is a critical NCLEX concept: altered mental status in an elderly patient should always prompt evaluation for urinary source. However, the clinical caveat is equally important — asymptomatic bacteriuria is common in older adults (prevalence up to 50% in elderly women in long-term care) and should not be treated without systemic symptoms. Pyuria and bacteriuria alone are insufficient criteria for antibiotic treatment in this population.
Pregnant patients: UTI symptoms may be vague or dismissed as pregnancy-related discomfort. Asymptomatic bacteriuria in pregnancy always requires treatment — untreated, it progresses to pyelonephritis in 25–30% of cases and is associated with preterm labor and low birthweight.
Catheterized patients: Dysuria and urgency are absent by definition. CAUTI presents with systemic signs: fever, rigors, new altered mental status, flank pain, or costovertebral tenderness. Pyuria and bacteriuria alone are expected in catheterized patients and do not indicate infection.
Diagnostic workup
Urinalysis dipstick interpretation
| Dipstick finding | Sensitivity | Specificity | Clinical interpretation |
|---|---|---|---|
| Leukocyte esterase (LE) | 62–98% | 55–96% | Marker of WBCs (pyuria); best screening test for UTI |
| Nitrites | 19–48% | >90% | Positive with gram-negative organisms that reduce nitrates; high specificity but low sensitivity — negative does not rule out UTI |
| LE + nitrites both positive | ~75% | ~82% | Combined positivity has best predictive value |
| Blood (hematuria) | Variable | Variable | Supports UTI diagnosis; also seen with stones, trauma, malignancy |
| Protein | Low | Low | Non-specific; mild in cystitis from mucosal inflammation |
The critical teaching point: nitrites have high specificity but low sensitivity. A positive nitrite strongly supports UTI. A negative nitrite does not rule it out — organisms like S. saprophyticus, Enterococcus, and Pseudomonas do not reduce nitrates and will always produce nitrite-negative results.
Microscopy
| Microscopy finding | Normal / abnormal | Significance |
|---|---|---|
| WBCs (pyuria) | >10 WBCs/high-power field (hpf) | Abnormal; indicates urinary tract inflammation |
| WBC casts | Absent in cystitis | Presence indicates upper tract (renal) involvement — distinguishes pyelonephritis from cystitis |
| Bacteria | Absent in clean catch | Confirms bacteriuria |
| RBCs | 0–2/hpf | Hematuria; supports UTI but non-specific |
| Epithelial cells | Few | High numbers suggest contamination — repeat collection |
WBC casts are the single most important microscopy finding for differentiating upper from lower UTI. Their presence in a symptomatic patient confirms kidney involvement. See the full nursing lab values reference for normal urinalysis parameters.
Urine culture
Diagnostic threshold: ≥1,000 CFU/mL in symptomatic patients (updated IDSA guidance — the old threshold of 100,000 CFU/mL missed many true infections, as 20–40% of symptomatic women have counts below this level).
When to order urine culture:
| Population | Culture required? |
|---|---|
| Healthy woman, uncomplicated cystitis, typical symptoms | No — clinical diagnosis is sufficient |
| Male (any UTI) | Yes — always |
| Pregnant | Yes — always; screen for asymptomatic bacteriuria at first prenatal visit |
| Catheterized patient (CAUTI) | Yes — replace catheter first, then collect |
| Diabetic or immunosuppressed | Yes |
| Recurrent UTIs (≥3/year) | Yes |
| Treatment failure (symptoms persist at 48–72 hours) | Yes |
| Pyelonephritis (upper tract) | Yes — always |
Collection technique matters: Midstream clean-catch is standard. In catheterized patients, collect from the sampling port — never from the drainage bag (organisms colonize the bag and do not reflect bladder infection). Replace the catheter before culturing if CAUTI is suspected, as biofilm on the existing catheter contaminates results.
Differentiating cystitis from pyelonephritis
This comparison is a high-yield NCLEX concept. The key differentiators are the presence of fever, systemic symptoms, and CVA tenderness.
| Feature | Cystitis (lower tract) | Pyelonephritis (upper tract) |
|---|---|---|
| Fever | Absent or low-grade (<38°C) | Present — typically ≥38°C, often high-grade with rigors |
| Flank / CVA pain | Absent | Present — hallmark finding |
| CVA tenderness on exam | Absent | Positive — confirmed by fist percussion at costovertebral angle |
| Nausea / vomiting | Absent | Common |
| Dysuria / frequency | Present — primary symptoms | May be present (concurrent lower UTI) |
| Systemic illness | Absent — patient "feels sick but functional" | Present — patient appears ill |
| WBC casts on UA | Absent | Present — confirms renal involvement |
| Serum WBC | Usually normal or mildly elevated | Leukocytosis, often with left shift |
| Bacteremia risk | Negligible | Present in ~25–30% of hospitalized cases |
| Risk of urosepsis | Very low | Significant — especially with obstruction or immunosuppression |
| Antibiotic route | Oral | Oral (outpatient) or IV (hospitalized) |
| Treatment duration | 3–7 days | 7–14 days |
For detailed pyelonephritis assessment, interventions, and urosepsis escalation, see the pyelonephritis nursing reference.
Nursing assessment
Systematic assessment priorities
Perform a head-to-toe assessment with emphasis on:
1. Urinary symptoms — characterize fully
- Onset and duration: when did symptoms begin? Sudden onset suggests acute infection
- Dysuria: burning throughout voiding vs terminal dysuria (more common in cystitis vs urethritis)
- Frequency: how many times per hour? Voiding small amounts suggests bladder irritation
- Urgency: can the patient delay voiding?
- Hematuria: visible blood? Pink-tinged vs gross hematuria?
- Urine appearance: cloudy, foul-smelling?
- Prior UTIs: number per year, prior cultures, antibiotic history
2. Vital signs — see vital signs by age for normal parameters
| Vital sign | Normal in cystitis | Red flag — consider upper tract |
|---|---|---|
| Temperature | <38°C | ≥38°C — fever suggests pyelonephritis |
| Heart rate | Normal | Tachycardia (HR >90) — systemic infection or dehydration |
| Blood pressure | Normal | Hypotension (SBP <100) — early sepsis |
| Respiratory rate | Normal | RR ≥22 — sepsis criterion (qSOFA) |
3. Abdominal / flank exam
- Suprapubic palpation: tenderness directly over the bladder suggests cystitis
- CVA percussion: firm fist percussion at the costovertebral angle. Any tenderness = upper tract involvement until proven otherwise. Assess bilaterally.
- Absence of CVA tenderness supports lower tract disease
4. Document key questions
- Recent antibiotic use (affects organism susceptibility and culture interpretation)
- Sexual history and contraceptive method (diaphragm/spermicide use)
- Pregnancy status (urine hCG in women of childbearing age before prescribing antibiotics)
- Catheter: current or recent indwelling catheter use?
- Diabetes, immunosuppression, renal disease, urologic abnormalities
- Allergies — especially sulfa (TMP-SMX) and penicillin
Nursing interventions
Intervention summary
| Intervention | Rationale |
|---|---|
| Collect urine specimen before antibiotic administration | Antibiotics sterilize culture results — collect clean-catch midstream before first dose |
| Administer antibiotics as ordered; verify allergy status first | Safe medication administration — verify 8 rights before each dose |
| Encourage oral fluids (2–3 L/day unless contraindicated) | Increased urine flow mechanically flushes bacteria from the bladder; dilutes bacteriuria |
| Monitor intake and output | Ensures adequate urine output; oliguria may indicate upper tract involvement or dehydration |
| Administer phenazopyridine if ordered | Urinary analgesic (turns urine orange-red); relieves dysuria but does not treat infection — educate patient on color change |
| Apply heat to suprapubic area | Relieves bladder spasm and suprapubic discomfort |
| Monitor for signs of upper tract progression | Fever development, new flank pain, CVA tenderness, nausea — escalate immediately if present |
| Patient education before discharge | Medication adherence, hydration, hygiene, return precautions |
Medication administration considerations
Before administering UTI antibiotics, verify:
- Allergies — sulfa allergy contraindicates TMP-SMX; note any cross-reactivities
- Pregnancy status — nitrofurantoin and TMP-SMX have gestational restrictions (see Special populations)
- Renal function — nitrofurantoin requires adequate renal function (avoid if eGFR <30 mL/min — it does not achieve therapeutic urine concentrations and may cause peripheral neuropathy)
- Culture obtained — if ordered, confirm specimen was collected before administering first dose
Phenazopyridine patient education
Phenazopyridine (Pyridium, AZO) is frequently prescribed for symptom relief. Educate patients:
- It is a urinary analgesic — it treats pain, not infection
- Urine will turn bright orange-red — this is expected and harmless; it will stain clothing and contact lenses
- Take only for the first 1–2 days while awaiting antibiotic effect
- Symptoms should begin improving within 24–48 hours of antibiotic initiation; if not, return for evaluation
Antibiotic reference
First-line agents for uncomplicated cystitis
| Agent | Duration | Key considerations | Avoid in |
|---|---|---|---|
| Nitrofurantoin (Macrobid) | 5–7 days | First-line; concentrated in urine; effective vs most E. coli; low resistance pressure | eGFR <30; late pregnancy (≥36 weeks); men (poor tissue penetration for prostate) |
| Trimethoprim-sulfamethoxazole (TMP-SMX, Bactrim) | 3 days | First-line when local resistance <20%; inexpensive; widely used | Sulfa allergy; first trimester and near term in pregnancy; known high resistance area |
| Fosfomycin (Monurol) | Single dose (3g) | Single-dose convenience; good coverage including ESBL strains; expensive | Pregnancy (limited data); upper tract infection (insufficient tissue levels) |
| Fluoroquinolones (ciprofloxacin, levofloxacin) | 3 days | Not first-line for uncomplicated cystitis — reserve for pyelonephritis; high resistance rates; FDA warnings re: tendinopathy, peripheral neuropathy | Tendon disorders; pregnancy (risk of fetal cartilage damage); use only when first-line agents inappropriate |
| Cephalexin (first-generation cephalosporin) | 7 days | Alternative when other agents contraindicated; broader spectrum than needed for simple cystitis | Cephalosporin allergy |
The fluoroquinolone stewardship point: IDSA guidelines specifically recommend against using fluoroquinolones as first-line treatment for uncomplicated cystitis. They are highly effective but carry resistance development risk that should be preserved for more serious infections (pyelonephritis, prostatitis). Nurses should recognize this when reviewing orders — fluoroquinolone prescriptions for simple cystitis may warrant a pharmacist or provider discussion.
Antibiotic duration by population
| Population | Recommended duration |
|---|---|
| Uncomplicated cystitis (healthy woman) | 3–5 days (nitrofurantoin: 5–7 days) |
| Men (all UTIs considered complicated) | ≥7 days |
| Pregnant patients | 5–7 days (based on agent) |
| CAUTI | 7 days (mild-moderate); 10–14 days (severe) |
| Elderly patients | 7 days (shorter courses have higher failure rates) |
Special populations
CAUTI (catheter-associated urinary tract infection)
CAUTI is the most common healthcare-acquired infection and a major driver of antibiotic resistance. Catheter biofilm forms within 24–48 hours of insertion, providing a scaffold for bacterial colonization.
CAUTI diagnosis requires all three:
- Indwelling urinary catheter in place for ≥2 days (or removed within the prior 48 hours)
- At least one sign or symptom: fever (≥38°C), rigors, altered mental status, new flank pain or CVA tenderness, pelvic discomfort, hematuria
- Urine culture growing ≥1,000 CFU/mL of a single uropathogen
Critical distinction: Pyuria and bacteriuria alone are NOT sufficient for CAUTI diagnosis. Virtually all patients with long-term catheters have asymptomatic bacteriuria. Treating asymptomatic bacteriuria in catheterized patients drives antibiotic resistance without clinical benefit.
CAUTI prevention bundle (evidence-based nursing practices):
| Bundle element | Rationale |
|---|---|
| Avoid unnecessary catheterization — use alternatives (condom catheter, intermittent catheterization, bladder scanner) | No catheter = no CAUTI risk |
| Insert using sterile technique | Reduces inoculation at time of insertion |
| Maintain closed drainage system — no disconnections | Breaks in the closed system are the primary route of ascending contamination |
| Keep drainage bag below bladder level at all times | Prevents retrograde flow of colonized urine into the bladder |
| Secure catheter to prevent tugging | Reduces urethral trauma and meatal contamination |
| Daily nursing assessment: is the catheter still necessary? | Document indication daily; remove at earliest opportunity |
| Remove promptly when no longer indicated | Risk increases with each day catheter remains in place |
| Perform meatal hygiene during routine bathing | Clean with soap and water — antiseptic ointments do not reduce CAUTI |
CAUTI organisms differ from community UTI: In addition to E. coli, CAUTI commonly involves Candida spp. (24%), Enterococcus (14%), Pseudomonas aeruginosa (10%), and Klebsiella (10%). Broader empiric coverage may be needed compared to community-acquired cystitis.
UTI in pregnancy
UTI is the most common bacterial infection in pregnancy, occurring in approximately 8% of pregnant women. The physiological changes of pregnancy — ureteral dilation from progesterone, uterine compression of ureters, increased urinary stasis — dramatically increase the risk of ascending infection.
Asymptomatic bacteriuria in pregnancy must be treated. This is a definitive NCLEX concept that distinguishes obstetric from general practice. Without treatment, 25–30% of pregnant women with asymptomatic bacteriuria develop pyelonephritis, which is associated with preterm labor, low birthweight, and maternal sepsis.
Antibiotic considerations in pregnancy:
| Agent | Pregnancy safety |
|---|---|
| Nitrofurantoin | Safe in first and second trimester; avoid at ≥36 weeks (risk of neonatal hemolytic anemia) |
| Cephalexin | Safe throughout pregnancy — preferred alternative |
| Amoxicillin-clavulanate | Acceptable; higher resistance rates |
| TMP-SMX | Avoid in first trimester (folate antagonism, neural tube defects) and near term (neonatal hyperbilirubinemia) |
| Fluoroquinolones | Avoid — risk of fetal cartilage damage |
| Fosfomycin | Limited safety data in pregnancy |
All pregnant patients with UTI require a test-of-cure culture 1 week after completing antibiotics. Recurrent or persistent bacteriuria in pregnancy may warrant prophylaxis through delivery.
UTI in elderly patients
Elderly patients present significant diagnostic challenges for two reasons that work in opposite directions: first, typical symptoms may be absent; second, asymptomatic bacteriuria is extremely prevalent (up to 50% of elderly women in long-term care) and does not require treatment.
When to suspect UTI in the elderly:
- New or acutely worsening confusion (delirium)
- Sudden functional decline, increased falls
- New incontinence in a previously continent patient
- Systemic signs: fever, rigors (though fever may be blunted in the elderly)
When not to treat:
- Bacteriuria on urine culture without any new systemic symptoms
- Chronic confusion without acute change from baseline
- Pyuria alone in an asymptomatic patient
The clinical and nursing responsibility is to obtain a thorough history establishing the patient’s baseline mental status and functional level. Acute change from baseline is the key trigger for evaluation, not a positive urine culture in isolation.
UTI in men
UTIs in men are uncommon before age 50. When they occur, all male UTIs are classified as complicated — the concern is prostatitis involvement, structural urinary tract abnormality, or an underlying condition that permitted a pathogen to establish infection in the male bladder.
Key points for male UTIs:
- Culture is mandatory — always
- Minimum treatment duration is 7 days; if prostatitis is suspected, 4–6 weeks of fluoroquinolone may be required (fluoroquinolones achieve prostate tissue penetration that other agents do not)
- Recurrent UTIs in men warrant urologic evaluation
- Nitrofurantoin has poor tissue penetration in male reproductive organs — avoid as sole agent
Prevention
Patient education for recurrent UTI prevention
Evidence-based prevention strategies to teach patients:
- Void after sexual intercourse — flushes bacteria introduced during intercourse before they can ascend; most effective single prevention strategy for sexually active women with recurrent UTIs
- Adequate daily hydration — at least 2–3 liters of fluid daily; increased urine flow reduces bacterial dwell time in the bladder
- Wipe front to back after urination and bowel movements (women) — prevents fecal bacterial contamination of the urethra
- Avoid prolonged voiding delay — do not hold urine for extended periods; stasis promotes bacterial growth
- Shower preference over baths — reduces prolonged perineal exposure to bath water bacteria
- Avoid spermicide use — spermicides eliminate protective vaginal lactobacilli; switch contraceptive method if recurrent UTIs correlate with diaphragm/spermicide use
- Loose-fitting, cotton underwear — reduces perineal moisture and warmth that promotes bacterial growth
Topical estrogen for postmenopausal women
Vaginal estrogen (cream, ring, or suppository) restores the lactobacilli-dominant vaginal flora that protects against uropathogenic colonization. It significantly reduces UTI recurrence in postmenopausal women and is recommended in appropriate candidates. Systemic estrogen does not confer the same benefit.
Cranberry products
Cranberry products contain A-type proanthocyanidins that theoretically prevent E. coli fimbriae from adhering to the urothelium. Clinical trial data is mixed — some studies show 30–40% reduction in UTI recurrence, others show no benefit. Current evidence is insufficient for a definitive recommendation, but cranberry products are safe, low-risk, and may provide modest benefit in high-recurrence patients. They are an adjunct, not a substitute for antibiotic prophylaxis in high-risk patients.
Antibiotic prophylaxis
For women with ≥3 UTIs per year, options include:
- Post-coital prophylaxis (single antibiotic dose within 2 hours of intercourse) — most targeted approach for coitally associated recurrence
- Continuous low-dose prophylaxis (nitrofurantoin 50 mg nightly, or TMP-SMX half-tablet nightly) — reduces recurrence by 95% but requires ongoing antibiotic exposure
- Self-start therapy (patient-initiated antibiotics at onset of symptoms without waiting for provider visit) — appropriate for motivated patients with reliable symptom recognition
Complications
Ascending infection to pyelonephritis
Untreated or inadequately treated cystitis can ascend via the ureters to the renal pelvis and parenchyma, causing pyelonephritis. Risk is highest with:
- Virulent organisms with strong adhesion properties
- Urinary stasis or obstruction
- Vesicoureteral reflux
- Immunosuppression
Warning signs of ascent: development of fever, new flank pain, CVA tenderness, nausea, or worsening clinical picture in a patient being treated for cystitis. See the pyelonephritis nursing reference for full management.
Urosepsis
Bacteria that ascend to the kidney may enter the bloodstream (bacteremia), triggering the systemic inflammatory cascade of sepsis. This is primarily a complication of pyelonephritis, not uncomplicated cystitis — but it is the reason that cystitis with fever must be taken seriously and escalated promptly. Urosepsis carries 30–40% mortality. See the sepsis nursing reference for sepsis bundle management.
Acute kidney injury
Severe upper tract infection with bacteremia, hypoperfusion, or urinary obstruction can precipitate acute kidney injury. Monitor creatinine, BUN, and urine output in any patient with UTI who has fever, hypotension, or oliguria.
Antibiotic resistance
Recurrent UTIs treated with repeated antibiotic courses — especially fluoroquinolones — drive emergence of resistant organisms including ESBL-producing E. coli. ESBL strains are resistant to cephalosporins and penicillins and require carbapenem therapy. Antibiotic stewardship in UTI management (using narrow-spectrum first-line agents, avoiding fluoroquinolones for uncomplicated cystitis) is a nursing responsibility as well as a prescriber responsibility.
NCLEX practice questions
Question 1
A nurse is assessing a 24-year-old woman with dysuria, urinary frequency, and urgency for the past two days. Her temperature is 37.1°C, HR 78 bpm. Dipstick urinalysis shows leukocyte esterase positive, nitrites negative. Which interpretation is most accurate?
A. The negative nitrite result rules out a urinary tract infection B. The findings are consistent with lower urinary tract infection; nitrites may be negative with certain organisms C. The absence of fever indicates no infection is present D. A negative nitrite with positive leukocyte esterase indicates vaginal contamination
Answer: B
Rationale: Leukocyte esterase is the more sensitive dipstick marker for UTI (62–98% sensitivity vs 19–48% for nitrites). Nitrites have high specificity but low sensitivity — a negative nitrite result does not rule out UTI. Organisms such as Staphylococcus saprophyticus (the second most common cause of UTI in young women), Enterococcus, and Pseudomonas do not reduce nitrates and will always produce nitrite-negative results on dipstick. Fever is absent in uncomplicated cystitis — its absence does not exclude lower tract infection. The clinical picture (dysuria, frequency, urgency) combined with positive leukocyte esterase is consistent with cystitis.
Question 2
A nurse is reviewing the urinalysis of a patient admitted with flank pain, fever of 38.9°C, and costovertebral angle tenderness. The microscopy report shows WBC casts. Which conclusion is most appropriate?
A. WBC casts are a normal finding in the setting of fever B. WBC casts confirm that the infection involves the renal parenchyma C. WBC casts indicate bladder irritation from cystitis D. WBC casts are a non-specific finding with no diagnostic value
Answer: B
Rationale: WBC casts form when white blood cells become embedded in the protein matrix of renal tubular casts. Their presence in the urine confirms renal parenchymal inflammation — they are the single most specific urinalysis finding for upper tract infection (pyelonephritis) and definitively distinguish it from lower tract infection (cystitis). WBC casts are never a normal finding. They are not associated with bladder inflammation alone. Combined with this patient’s fever, flank pain, and CVA tenderness, WBC casts confirm pyelonephritis.
Question 3
A nurse is caring for an 82-year-old woman in a long-term care facility. The patient has new confusion over the past 24 hours, has had two falls today, and her urine appears cloudy. A urinalysis shows pyuria and bacteriuria. Which action is most appropriate?
A. Begin empiric antibiotics immediately based on the urinalysis B. Notify the provider and obtain a urine culture; withhold antibiotics until clinical reassessment is complete C. Document the findings as expected for her age and reassess in 24 hours D. Collect a repeat urinalysis from the drainage bag to confirm the result
Answer: B
Rationale: Asymptomatic bacteriuria is extremely prevalent in elderly women (up to 50% in long-term care) and should not be treated with antibiotics. However, this patient has acute change from her baseline — new confusion and falls. These may represent systemic infection. The appropriate action is to notify the provider, obtain a urine culture (to guide antibiotic selection if treatment is warranted), and conduct a comprehensive assessment. Starting antibiotics based on pyuria and bacteriuria alone — without a provider assessment confirming symptomatic infection — is inappropriate. Collecting urine from the drainage bag is never correct, as drainage bags are colonized and do not reflect bladder urine.
Question 4
A nurse is preparing discharge teaching for a 28-year-old woman with her third UTI in six months. She asks what she can do to prevent recurrences. Which instruction has the strongest evidence base?
A. “Drink cranberry juice every day — it will prevent bacteria from sticking to your bladder.” B. “Urinate immediately after sexual intercourse to flush bacteria from the urethra.” C. “Avoid all baths and only shower going forward.” D. “Use a diaphragm as your contraceptive method to reduce UTI risk.”
Answer: B
Rationale: Post-coital voiding is the single most evidence-supported behavioral intervention for prevention of sexually associated recurrent UTI. It mechanically flushes bacteria introduced during intercourse before they can ascend. Cranberry products (option A) have mixed trial data — some benefit has been shown but evidence is insufficient for a definitive recommendation; cranberry juice alone is not adequate prevention for a patient with three UTIs in six months. Shower preference (option C) is recommended but has weaker evidence than post-coital voiding. Diaphragm use (option D) increases UTI risk because spermicides alter vaginal flora — the nurse should actually recommend she consider a different contraceptive method if UTI recurrence correlates with coital activity.
Question 5
A nurse is administering nitrofurantoin to a patient with uncomplicated cystitis. The patient reports she is 38 weeks pregnant. Which action should the nurse take first?
A. Administer the medication as ordered — nitrofurantoin is safe throughout pregnancy B. Hold the medication and notify the provider — nitrofurantoin is contraindicated at ≥36 weeks gestation C. Crush the tablet and mix with food to reduce gastrointestinal upset D. Administer the medication but document the pregnancy for follow-up
Answer: B
Rationale: Nitrofurantoin is safe in the first and second trimester of pregnancy for lower UTI treatment. However, it is contraindicated at ≥36 weeks gestation due to the risk of neonatal hemolytic anemia — fetal RBCs have insufficient glutathione instability protection at this gestational age. At 38 weeks, nitrofurantoin should be held and the provider notified immediately. A safe alternative — such as cephalexin — should be ordered instead. This is a medication safety scenario: the nurse must recognize the contraindication before administration, not after.
Question 6
A patient with an indwelling urinary catheter has a temperature of 38.4°C and new confusion. Urinalysis shows pyuria and bacteriuria. Before initiating treatment for CAUTI, which action is the highest priority?
A. Begin empiric broad-spectrum antibiotics immediately B. Replace the indwelling catheter and collect a urine specimen from the new catheter’s sampling port C. Remove the catheter permanently — CAUTI cannot be treated while a catheter is in place D. Collect a urine sample from the drainage bag for culture
Answer: B
Rationale: For suspected CAUTI, the catheter should be replaced before obtaining a urine culture specimen. Biofilm on the existing catheter colonizes the catheter lumen with organisms that do not necessarily represent the bladder infection — culturing from the old catheter or its drainage bag gives unreliable results. Replacing the catheter and collecting from the new catheter’s sampling port provides an accurate culture. The drainage bag (option D) is never an appropriate collection site — it is always colonized. Antibiotics should be initiated based on clinical severity after cultures are collected — empiric therapy is appropriate but should not precede culture collection when the clinical situation allows a brief delay. Permanent catheter removal is the goal where clinically possible, but treating CAUTI with antibiotics while a catheter remains in place is sometimes necessary when the catheter cannot be removed.
Related pages
- Pyelonephritis nursing reference — upper UTI, urosepsis, IV antibiotic management
- Sepsis nursing reference — full sepsis bundle for urosepsis escalation
- AKI nursing reference — acute kidney injury as a UTI complication
- AKI nursing — acute kidney injury assessment and interventions
- Nursing lab values cheat sheet — urinalysis normal parameters
- Head-to-toe assessment — systematic assessment framework
- Vital signs by age — normal vital sign parameters
- Medication rights in nursing — safe antibiotic administration
This reference was written for nursing students preparing for clinical practice and NCLEX. Clinical decisions must always be made in conjunction with current institutional protocols, provider orders, and individualized patient assessment.
Author: Lindsay Smith, AGPCNP
Sources: Urinary Tract Infection (UTI) — StatPearls, NCBI Bookshelf (NBK470195); Catheter-Associated Urinary Tract Infections (CAUTI) — StatPearls, NCBI Bookshelf (NBK436013); Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for UTI; CDC Healthcare-Associated Infections — CAUTI data.